Skip to main content
Journal ArticleOPEN ACCESS

Cariprazine versus placebo for schizophrenia

Cochrane Database of Systematic Reviews (2016) 2016(5)
DOI: 10.1002/14651858.CD012207
3Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy and safety of cariprazine compared to placebo for treating the symptoms of schizophrenia.

Cite

CITATION STYLE

APA

Essali, N., Hanafi, I., & Essali, A. (2016). Cariprazine versus placebo for schizophrenia. Cochrane Database of Systematic Reviews, 2016(5). https://doi.org/10.1002/14651858.CD012207

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free